Patent Assignment
Reel/Frame 072952/0173
Change of Name
Recorded: 2025-09-23
Pages: 2
Assignor
MELINTA THERAPEUTICS, INC
Executed: 2020-10-30
Assignee
MELINTA THERAPEUTICS, LLC
300 GEORGE STREET, SUITE 301, NEW HAVEN, CONNECTICUT, 06511
Covered Property
(1)
Methods of Treatment Using Single Doses of Oritavancin
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Jan 8, 2018
From: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; CEM-102 PHARMACEUTICALS, INC.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 045019/0552 →
Assignment of Assignor's Interest
Feb 21, 2019
From: LEHOUX, DARIO; PARR, THOMAS R.; MOECK, GREGORY; ETIENNE, PIERRE
To: TARGANTA THERAPEUTICS CORP.
Reel/Frame 048400/0572 →
Assignment of Assignor's Interest
Feb 21, 2019
From: TARGANTA THERAPEUTICS CORP.
To: THE MEDICINES COMPANY
Reel/Frame 048400/0612 →
Assignment of Assignor's Interest
Feb 21, 2019
From: THE MEDICINES COMPANY
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 048407/0911 →
Amended and Restated Intellectual Property Security Agreement
Aug 25, 2022
From: TARGANTA THERAPEUTICS CORPORATION
To: SILICON VALLEY BANK
Reel/Frame 061314/0659 →
Termination and Release of Intellectual Property Security Agreement (Patents) at Reel 061314 and Frame 0659
Aug 29, 2025
From: SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY
To: TARGANTA THERAPEUTICS CORPORATION
Reel/Frame 073724/0550 →